Clinical trial NCT00000700 - References

HIV Infections — A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP

Citation(s)

•   Coombs RW, Collier AC, Allain JP, Nikora B, Leuther M, Gjerset GF, Corey L
  Plasma viremia in human immunodeficiency virus infection. N Engl J Med. 1989 Dec 14;321(24):1626-31.
•   De Gruttola V, Wulfsohn M, Fischl MA, Tsiatis A
  Modeling the relationship between survival and CD4 lymphocytes in patients with AIDS and AIDS-related complex. J Acquir Immune Defic Syndr (1988). 1993 Apr;6(4):359-65.
•   Fischl M, Parker CB, Pettinelli C, Wulfsohn M, Rasheed S
  The efficacy and safety of a lower dose of zidovudine in the treatment of patients with AIDS-associated PCP. Int Conf AIDS. 1990 Jun 20-23;6(1):138 (abstract no ThB20)
•   Fischl MA, Parker CB, Pettinelli C, Wulfsohn M, Hirsch MS, Collier AC, Antoniskis D, Ho M, Richman DD, Fuchs E, et al
  A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med. 1990 Oct 11;323(15):1009-14.
•   McMahon DK, Winkelstein A, Armstrong JA, Pazin GJ, Hawk H, Ho M
  Zidovudine therapy is associated with an increased capacity of phytohemagglutinin-stimulated cells to express interleukin-2 receptors. Pittsburgh AIDS Clinical Trial Unit. AIDS. 1991 May;5(5):491-6.
•   Richman DD, Grimes JM, Lagakos SW
  Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus. J Acquir Immune Defic Syndr (1988). 1990;3(8):743-6.
•   Rinaldo C, Huang XL, Piazza P, Armstrong J, Rappocciolo G, Pazin G, McMahon D, Gupta P, Fan Z, Zhang Z, et al
  Augmentation of cellular immune function during the early phase of zidovudine treatment of AIDS patients. J Infect Dis. 1991 Oct;164(4):638-45.
•   Unadkat JD, Collier AC, Crosby SS, Cummings D, Opheim KE, Corey L
  Pharmacokinetics of oral zidovudine (azidothymidine) in patients with AIDS when administered with and without a high-fat meal. AIDS. 1990 Mar;4(3):229-32.
•   Winkelstein A, McMahon D, Hawk H, Armstrong JA, Pazin GJ, Ho M
  AZT therapy is associated with an increased capacity of PHA-stimulated cells to express IL-2 receptors (IL-2R). Int Conf AIDS. 1989 Jun 4-9;5:281 (abstract no MBP355)
•   Wulfsohn M, Fischl M, Tsiatis A
  Predictors of survival among patients with AIDS receiving zidovudine. Int Conf AIDS. 1992 Jul 19-24;8(2):C314 (abstract no PoC 4419)

A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP

Details for clinical trial NCT00000700